Repeated Methamphetamine Administration Differentially Alters Fos Expression in Caudate-Putamen Patch and Matrix Compartments and Nucleus Accumbens by Jedynak, Jakub P. et al.
Repeated Methamphetamine Administration
Differentially Alters Fos Expression in Caudate-Putamen
Patch and Matrix Compartments and Nucleus
Accumbens
Jakub P. Jedynak
2*, Courtney M. Cameron
1, Terry E. Robinson
1,2
1Department of Psychology, University of Michigan, Ann Arbor, Michigan, United States of America, 2Neuroscience Program, University of Michigan, Ann Arbor,
Michigan, United States of America
Abstract
Background: The repeated administration of psychostimulant drugs produces a persistent and long-lasting increase
(‘‘sensitization’’) in their psychomotor effects, which is thought to be due to changes in the neural circuitry that mediate
these behaviors. One index of neuronal activation used to identify brain regions altered by repeated exposure to drugs
involves their ability to induce immediate early genes, such as c-fos. Numerous reports have demonstrated that past drug
experience alters the ability of drugs to induce c-fos in the striatum, but very few have examined Fos protein expression in
the two major compartments in the striatum—the so-called patch/striosome and matrix.
Methodology/Principal Findings: In the present study, we used immunohistochemistry to investigate the effects of
pretreatment with methamphetamine on the ability of a subsequent methamphetamine challenge to induce Fos protein
expression in the patch and matrix compartments of the dorsolateral and dorsomedial caudate-putamen and in the ventral
striatum (nucleus accumbens). Animals pretreated with methamphetamine developed robust psychomotor sensitization. A
methamphetamine challenge increased the number of Fos-positive cells in all areas of the dorsal and ventral striatum.
However, methamphetamine challenge induced Fos expression in more cells in the patch than in the matrix compartment
in the dorsolateral and dorsomedial caudate-putamen. Furthermore, past experience with methamphetamine increased the
number of methamphetamine-induced Fos positive cells in the patch compartment of the dorsal caudate putamen, but not
in the matrix or in the core or shell of the nucleus accumbens.
Conclusions/Significance: These data suggest that drug-induced alterations in the patch compartment of the dorsal
caudate-putamen may preferentially contribute to some of the enduring changes in brain activity and behavior produced
by repeated treatment with methamphetamine.
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Introduction
Repeated intermittent exposure to drugs of abuse produces long
lasting changes in behavior, which are believed to be due to
alterations in patterns of neural activity within relevant brain
circuits [1,2]. In order to identify areas of the brain activated by
drugs of abuse the expression of immediate early genes, such as c-
fos or Fos protein, has proved useful [3,4]. Besides being a marker
of neuronal activation, it was recently reported that mice lacking
the c-fos gene do not develop locomotor sensitization to cocaine or
associated structural plasticity [5]. Thus, alterations in Fos
expression might help to identify neural circuits in the brain
related to the long-term changes in behavior produced by repeated
drug treatment.
One area of the brain that shows changes in Fos expression
following repeated treatment with cocaine and amphetamine is the
striatum. However, there have been conflicting reports in the
literature of tolerance, sensitization, or no effect on striatal Fos
expression following repeated drug treatment [6–8]. These
discrepant findings may be due to a number of factors, such as
differences in the environment in which drugs were administered,
or the neuroanatomical heterogeneity of the striatum [9,10]. That
is, Fos expression in the striatum can be examined in
histochemically distinct compartments: the patch/striosome and
the matrix. Neurons in these two areas contain different proteins
[11–13], they have different afferents and efferents [14–16], and
have different electrophysiological [17] and structural properties
[18], all of which could contribute to differences in neuronal
function between compartments. Not surprisingly, repeated drug
treatment results in compartmental differences in the pattern of
Fos expression. Specifically, repeated administration of cocaine or
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expression in the patch vs. matrix [19,20].
The purpose of the current study was to examine the effects of
repeated methamphetamine administration on Fos expression in
specific striatal compartments. However, unlike previous studies,
methamphetamine was administered in a novel environment,
which is known to produce more robust sensitization compared to
injections in the home cage and to facilitate striatal Fos expression
[21–23]. Furthermore, immunohistochemical techniques were
used to investigate drug-induced Fos expression in the patch vs.
matrix compartments of the dorsal striatum, and in the ventral
striatum or nucleus accumbens. In addition, an automated
behavioral analysis system was used to record and analyze
different types of drug-induced behaviors to assess the degree of
psychomotor sensitization.
Results
Effects of repeated methamphetamine administration on
psychomotor behavior
Figure 1 shows the effect of challenge injection of metham-
phetamine or saline on locomotor distance travelled (A and B),
locomotor velocity (C), and the frequency of head movements (D)
as a function of pretreatment condition. Analysis of the time
course for distance traveled in Figure 1A, resulted in no significant
interaction between pretreatment, challenge, and time
[F(23,1012)=0548; p=9590], therefore, the data were collapsed
over the entire session to simplify analysis. Methamphetamine
challenge [F(1,44)=71.529; P,0.0001)] and pretreatment
[F(1,44) = 4.250; P=0.0452)] resulted in higher levels of
locomotor distance as compared to saline (Figure 1B). However,
distance traveled in response to a saline or meth challenge did not
vary significantly as a function of past treatment [F(1,44)=1.458;
P=0.2336)], indicating that this measure did not provide evidence
of behavioral sensitization. Exposure to amphetamine can produce
behavior dominated by stereotyped actions; therefore, locomotor
distance is sometimes not the most sensitive measure of
sensitization [24]. For this reason, we also examined other aspects
of locomotor behavior, including velocity of locomotion [24].
Figure 1C shows a significant rightward shift in the average
velocity of locomotor bouts in methamphetamine challenged rats
that were pretreated with methamphetamine versus saline [Fish-
er’s Exact Test=12.027, df=5, p=0.012). Another indicator of
the intensity of stereotyped behaviors that occurs when animals are
not engaged in locomotion is the frequency of lateral head
movements. Repetitive head movements were analyzed immedi-
ately following methamphetamine and saline administration for
30 min, a time period where stereotyped behaviors are more
apparent than locomotor activity. The frequency of head move-
ments in response to methamphetamine or saline challenge varied
as a function of pretreatment [F(1,44)=16.976; P=0.0002].
Specifically, methamphetamine challenge enhanced frequency of
head movements in methamphetamine pretreated animals com-
pared to animals pretreated with saline (Figure 1D; t(22)=4.751,
p,0.0001). Thus, treatment with methamphetamine clearly
produced psychomotor sensitization, which was evident both in
the velocity of locomotion and the ability of a drug challenge to
produce repetitive head movements.
Effects of repeated methamphetamine administration on
Fos expression in the dorsolateral caudate-putamen
patch and matrix compartments
Examples of mu opiate receptor (MOR) and Fos immunos-
tained tissue along with template placement for Fos analysis in
dorsal striatum are shown in Figure 2. A methamphetamine
challenge increased Fos expression in both saline and metham-
phetamine pretreated groups relative to animals challenged with
saline, across all rostral-caudal levels in the patch compartment of
the dorsolateral caudate-putamen (Figure 3A). Levels of Fos
expression were higher in caudal than more rostral levels. There
was no significant interaction between pretreatment, challenge,
and rostral-caudal level [F(3,123)=0.662;=0.5769], so the data
were collapsed across all levels to simplify analysis (Figure 3B). The
methamphetamine challenge increased Fos expression significantly
more in methamphetamine versus saline pretreated animals as
indicated by a significant treatment by challenge interaction
[F(1,41)=8.839; p,0.0049].
In the matrix compartment of the dorsolateral striatum,
a methamphetamine challenge increased Fos expression in both
saline and methamphetamine pretreated groups, relative to a saline
challenge, across all rostral-caudal levels (Figure 3C). Similar to
the patch compartment, Fos expression was higher in caudal then
more rostral levels. A significant pretreatment, challenge, and
rostral-caudal level interaction was found [F(3,126)=2.839;
p=0.0407], due to a significant pretreatment by challenge
interaction at the most caudal level [F(1,42)=4.510; p=0.0395].
If the data were collapsed across rostral-caudal level there was no
significant difference in Fos expression between saline and
Figure 1. Psychomotor activity as function of treatment and
challenge. (a) Locomotor activity in 5 min blocks over 120 min. First
letter denotes pretreatment and second letter denotes challenge;
S=Saline; M=Methamphetamine (values=Mean6SEM). (b) Total loco-
motor distance over 120 min (values=Mean6SEM). (c) Number of rats
in specific average velocity ranges separated by pretreatment group. (d)
Frequency of head movements over 30 min (values=Mean 6SEM).
Asterisk denotes significant interaction between pretreatment and
challenge.
doi:10.1371/journal.pone.0034227.g001
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challenge [F(1,42 =2.029; p=0.1617; Figure 3D], although there
was a significant effect of past experience with methamphetamine
at the most caudal level examined (Figure 3C). Thus, with the
exception of bregma level 20.5, Fos expression in response to
methamphetamine challenge was enhanced in the dorsolateral
caudate-putamen patch but not matrix compartment of metham-
phetamine versus saline pretreated animals. Finally, methamphet-
amine challenge increased Fos expression to a greater extent in the
patch compared to the matrix, as indicated by a significant
interaction between pretreatment, challenge, and compartment
[F(1,368)=6.339; p,0.012].
Effects of repeated methamphetamine administration on
Fos expression in the dorsomedial caudate-putamen
patch and matrix compartments
In the patch compartment of the dorsomedial caudate-putamen,
a methamphetamine challenge increased Fos expression in both
salineandmethamphetaminepretreatedanimals,relativetoasaline
injection, across all rostral-caudal levels (Figure 4A). There was no
significantinteractionbetweenpretreatment,challenge,androstral-
caudal level [F(3,117)=0.550; p=0.6491], so the data were
collapsed across all levels (Figure 4B). In animals that had been
pretreated with methamphetamine, a challenge injection of
methamphetamine produced a greater increase in the number of
Fos-positivecellsthanitdidinsalinepretreatedanimals,asindicated
Figure 2. Images of MOR and Fos immunostained tissue. (a) Image of MOR immunoreactivity in the striatum. (b) Placement of templates used
for analysis of Fos expression in the dorsal caudate-putamen and nucleus accumbens core and shell. (c) Left, closeup image of MOR immunostained
tissue displaying the patch and matrix compartments. Middle, closeup image of Fos expression. Right, overlay of the left and middle images
demonstrating Fos expression in patch compartments.
doi:10.1371/journal.pone.0034227.g002
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p=0.0107; Figure 4B].
In the matrix compartment of the dorsomedial caudate-
putamen, a methamphetamine challenge increased Fos expression
in both saline and methamphetamine pretreated groups across all
rostral-caudal levels. There was no significant interaction between
pretreatment, challenge, and rostral-caudal level [F(3,117)=0.943;
p=0.4219 ], so the data were collapsed across all levels
(Figure 4D). The effect of past experience with methamphetamine
on the ability of a methamphetamine challenge to increase Fos
expression in this region was not quite statistically significant
[F(1,42)=3.919; p=0.0543; Figure 4D]. Furthermore, as in the
dorsolateral caudate-putamen, methamphetamine challenge in-
duced a greater number Fos positive cells in the patch compared
to the matrix (significant interaction between pretreatment x
challenge x compartment F(1,363)=3.934; p,0.048]).
Effects of repeated on methamphetamine administration
on Fos expression in the nucleus accumbens
A three-way interaction between pretreatment, challenge, and
rostral-caudal level was not significant in the core [f(2,88)=1.344,
p=0.2661] or shell [f(2,88)=0.398, p=0.6727], so data were
collapsed across all levels to simplify analysis. In both the core and
shell (Figure 5), a methamphetamine challenge increased Fos
expression in both saline and methamphetamine pretreated
groups, relative to saline challenge, however, there was no effect
of pretreatment condition [core: F(1,44)=1.792; p=0.1875; shell:
F(1,44)=0.126; p=0.7239].
Discussion
We found that repeated methamphetamine administration
produced an enhanced psychomotor response upon subsequent
exposure to methamphetamine, which is consistent with many
previous findings [25–27]. Pretreatment with methamphetamine
also enhanced methamphetamine-induced Fos expression prefer-
entially in the patch compartment of the dorsal caudate-putamen,
relative to both the matrix compartment of the dorsal striatum or
the nucleus accumbens core and shell regions. The compartmental
specificity of this form of ‘‘neural sensitization’’ may be related to
inherent biochemical and/or neuroanatomical differences be-
tween the patch and matrix.
The striatum is composed of two histochemically distinct
compartments organized in a mosaic fashion. Each compartment
can be visualized by examining biochemical markers specific to
each area. For example, the patch is rich with MOR receptors
[13,28] whereas the matrix contains high levels of calbindin [11]
and acetylcholinesterase [12]. In addition to differences in protein
expression, each compartment is differentially innervated by
afferents arising from midbrain dopaminergic and cortical
glutamatergic neurons. For instance, the patch is predominately
innervated by projections from the limbic cortices such as the
prelimibic and infralimbic areas [29] whereas the somatosensory
cortex innervates the matrix compartment [30]. These differences
in biochemical composition and cortical input support the notion
that neurons in each compartment possess unique physiological
properties. Unfortunately, due to the small volume that the patch
compromises of the total striatum, few studies have compared the
electrophysiological properties of cells in the patch versus the
matrix. Nevertheless, it is reported that cells in the patch have
higher resting membrane potential and input resistance [17].
Differences in MOR inhibition of inhibitory post synaptic currents
and the ability of NMDA receptors to modulate dopamine release
have also been observed between compartments [17,31]. These
neurobiological differences between the patch and matrix could
contribute to the compartmental differences in Fos expression
observed in this study.
Following repeated exposure to methamphetamine, the ability
of a subsequent injection of methamphetamine to increase Fos
expression was enhanced in the patch compared to matrix.
Preferential activation of the patch vs. matrix in sensitized animals
Figure 3. Fos expression in the patch and matrix compartments
of the dorsolateral caudate-putamen as a function of pre-
treatment, challenge, and bregma level. Left panels (a and c), Fos
expression across rostral-caudal levels. Right panels (b and d), Fos
expression collapsed across levels. Asterisk denotes significant in-
teraction between pretreatment and challenge (values=Mean6SEM).
doi:10.1371/journal.pone.0034227.g003
Figure 4. Fos expression in the patch and matrix compartments
of the dorsomedial caudate-putamen as a function of pre-
treatment, challenge, and bregma level. Left panels (a and c), Fos
expression across rostral-caudal levels. Right panels (b and d), Fos
expression collapsed across levels. Asterisk denotes significant in-
teraction between pretreatment and challenge (values=Mean6SEM).
doi:10.1371/journal.pone.0034227.g004
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reported only a relative enhancement in patch activation, which was
primarily due to a decrease in matrix activity, rather than an
increase in patch activity [19,20]. Thus, while others found no
change in patch activity following repeated amphetamine
administration, we report enhanced patch activation with little
to no change in matrix activity. These discrepant findings could be
due to a number of differences in experimental design. First, the
drug used here was methamphetamine rather than d-amphet-
amine. Methamphetamine was recently demonstrated to be more
effective at releasing DA and increasing internal calcium
concentrations relative to d-amphetamine [32], which may be
relevant to the drug-induced changes in Fos expression reported
here. Second, female rats were used in this study and drug-induced
Fos-expression in the striatum has been shown to be sexually
dimorphic [33,34]. Third, in the present study the daily injections
were given in a relatively novel and unique test environment,
whereas Canales & Graybiel [19] and Vanderschuren et al [20]
administered the drug in the animals’ home cage. This last point
may be especially important because previous experiments from
our laboratory have demonstrated that the context in which drugs
are administered can have a large effect on the ability of drugs to
produce sensitization and induce immediate early gene expression.
Badiani and colleagues have reported that psychomotor stimulant
drug administration in a novel environment enhances c-fos
expression in the caudate putamen and cortex significantly more
than when it is given in the home cage [22,23]. Moreover, the
extent of cortical activation differs in animals repeatedly treated
with amphetamine in a novel environment compared to those
treated in their home cage [35]. Specifically, prefrontal cortical
areas such as the prelimbic and infralimbic, which have been
shown to predominantly project to the patch compartment, show
greater increases in c-fos induction than the somatosensory cortex,
which projects to the matrix [35]. These cortical projections
release glutamate onto medium spiny neurons, a neurotransmitter
that has been shown to be involved in the induction of c-fos in the
striatum [36,37]. Different neuronal populations are also activated
when psychostimulant drugs are administered in home vs. novel
environments. Specifically, amphetamine administration in the
home cage induces c-fos gene expression primarily in the direct
pathway or substance p/dynorphin expressing cells, while
injections in a novel environment activate direct projections and
the indirect pathway or enkephalin containing cells as well [38,39].
Neuroanatomical studies have shown that the patch contains
a higher percentage of direct compared to indirect projections
[18,40] and enkephalin expression is more abundant in the matrix
[41]. Therefore, it’s possible that injections of methamphetamine
in the novel environment recruited indirect pathway neurons in
the matrix to overcome the decreases in matrix activation
observed by others following repeated amphetamine administra-
tion in the home cage [19,20]. We speculate that the administra-
tion of methamphetamine in a relatively novel test environment
may enhance neuronal activation in both the patch and matrix
compartments relative to when injections are given in the home
cage.
Past experience with methamphetamine had no significant
effect on Fos expression in the nucleus accumbens. This result was
unexpected since recent evidence suggests that Fos expression is
enhanced in the nucleus accumbens following chronic cocaine or
amphetamine administration in a novel environment [6,42].
However, others have reported no changes in Fos expression
following repeated amphetamine administration although drug
was administered in the home cage [20]. As mentioned above,
differences in the experimental design could account for these
discrepant findings. Moreover, the nucleus accumbens is a hetero-
geneous structure that can be segregated into territories based on
the distribution of various proteins and peptides or differences in
afferent and efferent connections [43,44]). Therefore, it is quite
possible that areas within the nucleus accumbens core and shell
regions that underwent neural sensitization were missed. A more
thorough analysis of the nucleus accumbens with emphasis on
inherent biochemical and neuroanatomical differences is war-
ranted.
Repeated exposure to methamphetamine produced psychomo-
tor sensitization and enhanced Fos expression preferentially in the
patch compartment of the dorsal caudate-putamen. The localiza-
tion of Fos sensitization to the patch but not the matrix could have
contributed to the behavioral changes produced by repeated
methamphetamine treatment. Unfortunately, little is known about
the different functional contributions of the patch and matrix
compartments to behavior. Some evidence suggests a role for the
patch in reward mechanisms since animals will more reliably
electrically self-stimulate when the electrode is located in the patch
relative to the matrix [45]. Others have demonstrated that
enhanced patch activation following repeated cocaine or amphet-
amine administration correlates with stereotyped motor move-
ments [19]. Another possible role for the patch stems from
neuroanatomical studies which demonstrate that limbic structures
such as the amygdala, which mediates incentive motivational
processes, primarily innervate the patch compared to the matrix
[14,46,47]. Of course, most studies examining motivation have
focused on the nucleus accumbens and related reward circuitry;
however, recent evidence suggests that the caudate-putamen
might contribute to incentive motivational functions. Specifically,
lesions of the dorsal caudate-putamen impair instrumental
Figure 5. Fos expression in the nucleus accumbens core and
shell as a function of treatment, challenge, and bregma level.
Left panels (a and c), Fos expression across rostral-caudal levels. Right
panels (b and d), Fos expression collapsed across levels. (values=-
Mean6SEM).
doi:10.1371/journal.pone.0034227.g005
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ian-to-instrumental-transfer task [48]. Also, dopamine restoration
in the caudate-putamen of tyrosine hydroxylase deficient mice
rescues motivated behaviors such as feeding [49,50]. Clearly, the
heterogeneous makeup of the striatum requires more studies to
elucidate the role of specific regions and compartments in different
behaviors and psychological components of reward [51].
In closing, there is a wealth of information recently available on
circuits and compartments within reward-related pathways such as
the caudate-putamen or nucleus accumbens that undergo changes
at the cellular, molecular and structural levels following repeated
drug administration. We report here that repeated treatment with
methamphetamine, which produced robust psychomotor sensiti-
zation, enhances neuronal activity in the patch but not matrix
compartment of the dorsal caudate-putamen. The hypersensitivity
of patch medium spiny neurons to subsequent drug exposure
might have important implications for the long-lasting behavioral
changes observed in animals repeatedly treated with metham-
phetamine. The challenge now is to understand how drug-induced
neuroadaptations in specific neural circuits affect the pathway’s
overall function and ultimately the behavior of the animal.
Materials and Methods
Ethics Statement
All procedures were approved by the University of Michigan
Committee on the Use and Care of Animals under protocol
number A3114-01.
Subjects
Forty-eight female Sprague-Dawley rats (Harlan Laboratories;
Indianapolis, IN) weighing 220–280 g were housed four per cage
in temperature and humidity controlled rooms. They were
maintained on a 12-h light:dark cycle with access to food and
water ad libitum. Animals were acclimatized to these conditions for
7 days prior to testing. Female rats were used because structural
and behavioral changes following repeated amphetamine admin-
istration have been observed to persist for months following drug
cessation [52,53].
Groups and test procedures
On treatment days animals were transported from their home
cages to activity chambers (33.02668.58660.96 cm) with woven
wire grid floors, PVC sides, and cameras (SPE-57, CCTV
Specialty Bullet Cameras, Lake Worth, Florida, USA). At the
beginning of each session, animals were allowed to habituate to the
chamber for 30 minutes before receiving an intraperitoneal (IP)
injection of either d-methamphetamine HCl (2 mg/kg, weight of
the salt; n=24) or saline (n=24). After the 5
th pretreatment day,
animals remained in their home cages for 7 days during which no
drug treatments were given. Following this drug-free period, saline
and methamphetamine pretreated rats received a challenge
injection of either saline or 1 mg/kg methamphetamine, as during
the pretreatment phase, resulting in 4 groups: 1) Rats pretreated
with methamphetamine and challenged with saline (MS; n=12);
2) rats pretreated with methamphetamine and challenged with
methamphetamine (MM; N=12); 3) rats pretreated with saline
and challenged with saline (SS; N=12) and 4) rats pretreated with
saline and challenged with methamphetamine (SM; N=12).
Following the challenge injection, behavior was recorded for
120 minutes via a Pelco DX9100 (Clovis, CA) digital video
recorder.
Behavior
Videos captured by the Pelco digital video recorder system were
analyzed using TopScan Software (CleverSys, Inc. Reston,
Virginia, USA). Behavioral parameters defined specifically for
quantification of drug-induced psychomotor activity were used to
analyze locomotion and head movements [24]. Locomotion was
defined as a forward movement in which the animal traveled
a minimum distance of 110 mm. From the locomotor data,
distance (mm) traveled and velocity (mm/s) for each locomotor
bout was calculated. For analysis, the total distance and average
velocity for each movement over 2 h was calculated for each
animal. Lateral head movements were defined as deviations of at
least 10 degrees from the center of the body when the animal was
stationary for at least 2 s. The frequency of head movements was
calculated by dividing the total number of head movements by the
time spent in place. For analysis, the average frequency of head
movements for 30 min following saline or meth administration
was calculated for each animal.
Immunohistochemistry
Two hours after the final challenge injection, rats were deeply
anesthetized with sodium pentobarbital (Fatal Plus; Vortech
Pharmaceuticals, Dearborn, MI) and transcardially perfused with
150 mL of phosphate buffered saline (PBS; pH=7.4) followed by
300 mL of 4% paraformaldehyde (PFA; pH=7.4) at 30 mL/min.
Brains were postfixed in 4% PFA at 4uC for 24 h and then
transferred to a 30% sucrose/PBS solution for an additional 24 h
at 4uC. Following sucrose infiltration, 40 mm coronal sections were
prepared on a microtome (Leica Microsystems; Wetzlar, Ger-
many) and stored in wells containing PBS at 4uC. Free-floating
sections were washed in PBS for 5 min and placed in blocking
buffer (5% normal donkey serum and 0.4% Triton X-100 in PBS)
for 1 h at room temperature. Sections were simultaneously incubated
in primary antibodies goat anti-Fos (sc-52-G; Santa Cruz
Biotechnology; Santa Cruz, CA) diluted 1:500 in blocking buffer
and rabbit anti-mu opioid receptor (ab10275; Abcam; Cambridge,
UK) diluted 1:2000 in blocking buffer for 24 h at 4uC. The next
day, sections were washed six times for 10 min in PBS and placed
in blocking buffer with Image-IT FX signal enhancer (Invitrogen;
Carlsbad, CA) for 1 h at room temperature. Sections were
simultaneously incubated in secondary antibodies donkey anti-
goat (Alexa Fluor 488; Invitrogen) and donkey anti-rabbit (Alexa
Fluor 594; Invitrogen) diluted 1:250 in blocking buffer containing
signal enhancer for 2 h. Sections were washed six times for 10 min
in PBS, mounted on Fisherbrand Superfrost/Plus slides (Thermo
Fisher Scientific Inc., Waltham, MA), and coverslipped with
Prolong Gold Antifade Reagent (Invitrogen). See Figure 2 for
images of MOR and Fos immunostained tissue. We like to
acknowledge that previous experiments examining psychostimu-
lant drug-induced Fos protein expression in the striatum [6,19]
used shorter post-fix lengths (2 h vs 24 h) and different detection
methods (DAB precipitate versus immunofluorescence detection)
which could have affected the results presented here.
Quantification of Immunohistochemistry
For each animal, Fos immunoreactivity was quantified in the
dorsolateral and dorsomedial caudate-putamen (approximately
+1.0, +0.5, 0.0 and 20.5 mm relative to Bregma) and the core and
shell subregions of the nucleus accumbens (approximately +2.25,
+2.0, and +1.75 relative to Bregma). See Figure 2 for placements
of templates in the caudate-putamen and nucleus accumbens.
Images were captured at 106magnification (NA 0.30) using a Leica
DMRX fluorescence microscope (Leica Microsystems, Wetzlar,
Germany) attached to a Sony DXC-970 MD color video camera
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and MOR-immunoreactivity were captured and analyzed using
MCID software (InterFocus Imaging Ltd., Linton, England).
During image acquisition, exposure time was held constant and
the signal gain was decreased until the background pixel intensity
was 0.01 Relative Optical Density (ROD) units. To obtain counts
of Fos-positive cells, a pixel intensity threshold of 0.03 RODs was
set to allow for detection of cells that were three times the intensity
of the background. During analysis, an image of Fos-positive cells
and its corresponding MOR image were opened in two separate
channels. A rectangular template was placed in the target region
(DL and DM caudate-putamen, 1.34 mm
2; nucleus accumbens
core, 0.27 mm
2; and nucleus accumbens shell, 0.20 mm
2) of the
MOR-stained image, and the software scanned the corresponding
area in the Fos-stained image to obtain overall cell counts. To
determine Fos density in specific compartments of the dorsal
striatum, MOR-positive regions (‘‘patches’’) were distinguished
from MOR negative regions (‘‘matrix’’) by using the Autoscan
feature in MCID. This tool automatically detects an edge between
a target and background when the target is clearly distinct from
the surrounding regions. Since the signal intensity in patches is
much greater than in the matrix, MCID was able to generate an
outline of the patch with the remaining areas of the image labeled
as the matrix. Cells in the corresponding Fos image were then
counted in an area based on the outline of the patch. To calculate
the density of Fos-positive cells in the matrix, the number of cells
in the patch regions was subtracted from the total number of cells,
and patch area was subtracted from the total area. Fos counts were
expressed as the number of Fos-positive cells per mm
2. Single pixel
targets were automatically removed and other abnormal targets
were deleted manually. An observer blind to the experimental
conditions conducted all quantification.
Statistics
For behavioral analysis, a mixed model ANOVA was performed
to examine interactions between pretreatment, challenge, and
time. For quantification of Fos expression, a mixed model
ANOVA was performed to examine interactions between
treatment, challenge, and rostral-caudal level or compartment.
When no significant three-way interactions were observed, data
were collapsed across the entire time course or rostral-caudal level.
Two-way ANOVAs were then used to examine the effects of
treatment and challenge. In cases where the treatment x challenge
interaction reached significance, t-tests were used for pairwise
comparisons. A Fishers exact test was used to analyze the effect of
pretreatment on specific locomotor velocity ranges.
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